Chufeng Ding, Lin Ma, Yankun Liang, Zhenpo Zhang, Qimin Wu, Jun Lyu, Ling Su. "Gastrointestinal adverse events associated with Lenvatinib versus Lenvatinib plus Pembrolizumab: A pharmacovigilance study in FDA adverse event reporting system." Scientific Reports, 2025. doi:10.1038/s41598-025-99773-4